| Chikungunya: Evolutionary history and recent epidemic spread | Antiviral Research | 2015 | 251 |
| Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity | Proceedings of the National Academy of Sciences of the United States of America | 2020 | 138 |
| Zika in the Americas, year 2: What have we learned? What gaps remain? A report from the Global Virus Network | Antiviral Research | 2017 | 77 |
| A robust human norovirus replication model in zebrafish larvae | PLoS Pathogens | 2019 | 57 |
| Comparing infectivity and virulence of emerging SARS-CoV-2 variants in Syrian hamsters | EBioMedicine | 2021 | 50 |
| The combined treatment of Molnupiravir and Favipiravir results in a potentiation of antiviral efficacy in a SARS-CoV-2 hamster infection model | EBioMedicine | 2021 | 29 |
| Medical treatment options for COVID-19 | European Heart Journal: Acute Cardiovascular Care | 2020 | 27 |
| The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters. | Antiviral Research | 2022 | 27 |
| Molnupiravir Inhibits Replication of the Emerging SARS-CoV-2 Variants of Concern in a Hamster Infection Model | Journal of Infectious Diseases | 2021 | 27 |
| A structural basis for antibody-mediated neutralization of Nipah virus reveals a site of vulnerability at the fusion glycoprotein apex | Proceedings of the National Academy of Sciences of the United States of America | 2019 | 25 |
| Emerging preclinical evidence does not support broad use of hydroxychloroquine in COVID-19 patients | Nature Communications | 2020 | 24 |
| Ultralarge Virtual Screening Identifies SARS-CoV-2 Main Protease Inhibitors with Broad-Spectrum Activity against Coronaviruses. | Journal of the American Chemical Society | 2022 | 16 |
| Tiger in the sun: A report of Aedes albopictus in Jamaica | Acta Tropica | 2019 | 9 |
| 2018 international meeting of the Global Virus Network | Antiviral Research | 2019 | 7 |
| An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal models | Science Translational Medicine | 2021 | 7 |
| Reduced Nucleoprotein Availability Impairs Negative-Sense RNA Virus Replication and Promotes Host Recognition | Journal of Virology | 2021 | 7 |
| A dengue type 2 reporter virus assay amenable to high-throughput screening | Antiviral Research | 2020 | 2 |
| Assessment of commercial SARS-CoV-2 antibody assays, Jamaica | International Journal of Infectious Diseases | 2021 | 2 |
| Comparison of SARS-CoV-2 Receptors Expression in Primary Endothelial Cells and Retinoic Acid-Differentiated Human Neuronal Cells | Viruses | 2021 | 1 |
| Comparing immunogenicity and protective efficacy of the yellow fever 17D vaccine in mice | Emerging Microbes and Infections | 2021 | 0 |
| HIV protease inhibitors Nelfinavir and Lopinavir/Ritonavir markedly improve lung pathology in SARS-CoV-2-infected Syrian hamsters despite lack of an antiviral effect. | Antiviral Research | 2022 | 0 |
| Antiviral Targets and Strategies to Treat and Prevent Human Norovirus Infections | Methods and Principles in Medicinal Chemistry | 2022 | |
